Koos Koops, CEO of Xendo, and Ard Tijsterman, managing director Xendo Manufacturing & Xendo Pharma Services, gave an interview for Biotech News. In this interview issues like Xendo's history and business model are discussed. The interview also focuses on the upcoming production facility for biologicals and cell therapy products. Xendo will operate this facility, that makes use of innovative solutions for upstream and downstream processing, in 2007. For more information, read the full article (in Dutch)